Ameridose LLC, the Westborough pharmacy that agreed to suspend operations Wednesday because of its ties to the Framingham company at the center of the deadly outbreak of fungal meningitis outbreak, has faced questions about its own safety procedures before. In 2008, a US Food and Drug Administration inspection found Ameridose had significant problems with production records, procedures, and drug testing, according to Validation Times, an industry newsletter. In June of this year, a group-purchasing organization for hospitals also found serious problems during a visit to Ameridose.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help